Bang Debt/Equity
What is the Debt/Equity of Bang?
The Debt/Equity of Bang Holdings Corp. is -0.51
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Industrials sector on OTC compared to Bang
What does Bang do?
Bang Holdings Corp., a brand management and advertising technology company, provides content and an influencer-based marketing network to the cannabis industry. It operates 4TTnetwork, a multi-platform comprising TwentyToday, VaporBang, AmericanToker, and HighOnStocks; and Green Monkey Network, a network of social media influencers in the marijuana industry. Bang Holdings Corp. was incorporated in 2014 and is based in North Miami Beach, Florida.
Companies with debt/equity similar to Bang
- Vitro Diagnostics has Debt/Equity of -0.67
- Royale has Debt/Equity of -0.63
- McAfee has Debt/Equity of -0.61
- Enviro-Serv has Debt/Equity of -0.60
- Infinity Pharmaceuticals has Debt/Equity of -0.57
- Q BioMed has Debt/Equity of -0.51
- Bang has Debt/Equity of -0.51
- Invitae Corp has Debt/Equity of -0.49
- Inhibitor Therapeutics has Debt/Equity of -0.49
- Biostage has Debt/Equity of -0.44
- Gpo Plus Inc has Debt/Equity of -0.43
- Emisphere Technologies has Debt/Equity of -0.42
- Adamis Pharmaceuticals Corp has Debt/Equity of -0.41